Addition of Muramyl Tripeptide to Chemotherapy for Patients with Newly Diagnosed Metastatic Osteosarcoma: a Report from the Children's Oncology Group

BACKGROUND: The addition of liposomal muramyl tripeptide phosphatidylethanolamine (L-MTPPE) to chemotherapy has been shown to improve overall survival in patients with non-metastatic osteosarcoma (OS). We report the results of L-MTP-PE addition to chemotherapy for patients with metastatic OS. METHOD...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Chou, Alexander J., Kleinerman, Eugenie S., Krailo, Mark D., Chen, Zhengjia, Betcher, Donna L., Healey, John H., Conrad, Ernest U., Nieder, Michael L., Weiner, Michael A., Wells, Robert J., Womer, Richard B., Meyers, Paul A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2783515/
https://ncbi.nlm.nih.gov/pubmed/19637348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24566
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky